FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and concerns a method for detecting in a test sample the presence and/or binding properties of analyzed antibodies capable of reacting with one or more antigenic molecules, comprising (a) providing a first antigenic molecule selected from CRF; (b) providing a second antigenic molecule selected from CRF; (c) bringing the first antigen molecules and the second antigen molecules into contact with the sample to form complexes containing [a first antigenic molecule] - [analyzed antibody] - [second antigenic molecule]; (d1) providing an immobilisation means and/or (d2) providing a second tagging means; and (e) providing a first tagging means; and (g) detecting presence of complexes formed during or after step (c). Group of inventions also relates to a kit applicable for implementing said method; use of said method for diagnosing the presence or onset of a disease associated with a family of cardiac receptors.
EFFECT: group of inventions provides a fast, reliable, specific and sensitive method which enables to study low amounts of the analyte.
13 cl, 8 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
IL-1 ALPHA AND BETA BISPECIFIC IMMUNOGLOBULINS WITH DOUBLE VARIABLE DOMAINS AND THEIR APPLICATION | 2011 |
|
RU2627171C2 |
COMPLEMENTARY PEPTIDE TO PRIMARY IMMUNOGENIC ACETYLCHOLINE RECEPTOR REGION, BASED THERAPEUTIC COMPOSITION, METHOD OF PRODUCING AND USING PEPTIDE | 2006 |
|
RU2422458C2 |
IL-1 BINDING PROTEINS | 2011 |
|
RU2615173C2 |
PARTNERS OF SPECIFIC BINDING WITH NGF | 2006 |
|
RU2406728C2 |
METHOD FOR TREATMENT WITH BUCINDOLOL BASED ON GENOTYPE DEFINITION | 2005 |
|
RU2389798C2 |
TARGET-MODIFIED ENDOPEPTIDASE ACTIVITY IMMUNOASSAYS | 2010 |
|
RU2543650C2 |
COMPLEMENTARITY-DETERMINING REGIONS FOR BINDING CD3 AND A BISPECIFIC ANTIGEN-BINDING MOLECULE CONTAINING THEREOF | 2019 |
|
RU2738802C1 |
METHODS FOR IDENTIFYING COMPOUNDS USED FOR REGULATION OF MUSCLE MASS OR FUNCTION WITH APPLYING RECEPTORS OF CORTICOTROPIN RELEASING-FACTOR | 2002 |
|
RU2260805C2 |
GD2 BINDING MOLECULE | 2020 |
|
RU2824670C2 |
ANTI-IL-17F ANTIBODIES AND METHODS FOR USE THEREOF | 2010 |
|
RU2605318C2 |
Authors
Dates
2019-11-22—Published
2015-12-21—Filed